Species in Metabolics / Bifidobacterium Infantis Powder

  1. bifidobacterium infantis

Infer Impacts Metabolics / Bifidobacterium Infantis Powder on Symptoms

Probiotic:
Symptom:

Not sufficient information to infer impact

Bacteria Impacts of Metabolics / Bifidobacterium Infantis Powder

If you find any studies of this specific probiotic impacting other bacteria, please email ken/at/lassesen.com with the URI

This table is estimated from the impact of EACH species in the probiotics reported in clinical studies. In some cases, one species will increase and another decrease. Often, all of the species have similar (or no impact).

Genus Level Only Listed
BacteriaIncrease %Decrease %
Anaerorhabdus 0 100
Atlantibacter 0 100
Bacteroides 0 100
Bifidobacterium 100 0
Buttiauxella 0 100
Candida 0 100
Candida 0 100
Candidatus Ishikawaella 0 100
Candidatus Moranella 0 100
Candidatus Phlomobacter 0 100
Candidatus Profftia 0 100
Candidatus Riesia 0 100
Candidatus Schneideria 0 100
Cedecea 0 100
Citrobacter 0 100
Clostridium 100 0
Cronobacter 0 100
Dorea 100 0
Enterobacter 0 100
Enterococcus 0 100
Entomohabitans 0 100
Escherichia 0 100
Franconibacter 0 100
Jejubacter 0 100
Kluyvera 0 100
Kosakonia 0 100
Leclercia 0 100
Lelliottia 0 100
Mangrovibacter 0 100
Mediterranea 0 100
Metakosakonia 0 100
Phocaeicola 0 100
Phytobacter 0 100
Plesiomonas 0 100
Pluralibacter 0 100
Pseudescherichia 0 100
Pseudocitrobacter 0 100
Ralstonia 0 100
Salmonella 0 100
Scandinavium 0 100
Shigella 0 100
Shimwellia 0 100
Siccibacter 0 100
Trabulsiella 0 100
Yokenella 0 100

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.


The awesome web hosting site that we use. Try it if you need to host (or unhappy with current provider)